|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Preferred Stocks | ||||||||||||||||||||
| Series E, Preferred Stock | ||||||||||||||||||||
| Total preferred stock, value | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| House and real estate inventory | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current Assets | ||||||||||||||||||||
| Investments in equity securities | ||||||||||||||||||||
| Investments in equity securities, related party | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Note receivable, current | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Software costs | ||||||||||||||||||||
| Note receivable, $400,700 and $-0-, due from related party, respectively | ||||||||||||||||||||
| Advances to related party | ||||||||||||||||||||
| Advance to affiliated entity | ||||||||||||||||||||
| Advances to Affiliate | ||||||||||||||||||||
| Right of use asset | ||||||||||||||||||||
| Due from executive | ||||||||||||||||||||
| Employee loan receivable, net | ||||||||||||||||||||
| Advance to affiliated entity and related party | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Construction Loan | ||||||||||||||||||||
| Accrued expenses and advances, related party | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Accrued expenses, related party and advances due to executive | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Accrued expenses, related parties | ||||||||||||||||||||
| Due to executive | ||||||||||||||||||||
| Notes payable, related party, net of discounts | ||||||||||||||||||||
| Convertible notes payable, net of discounts | ||||||||||||||||||||
| Notes payable, related party | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Convertible notes payable, net | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term note payable, net of current portion | ||||||||||||||||||||
| Right-of-use liability | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Common stock, 3,000,000,000 shares authorized, $0.001 par value, 231,905,314 and 140,099,049 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common stock, 450,000,000 shares authorized, $0.001 par value, 112,380,049 and 16,785,000 issued and outstanding as of December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...